Data visibility gap grows as AI deployments surge ahead

New research from Veeam® Software shows a growing data disconnect across EMEA organisations. While 99% of enterprise decision-makers agree that data sovereignty is critical, at the organisational level, the majority (72,5%) are actively deprioritising it in favor of...

The biggest credit crisis in SA is not debt. It is access

Every year, millions of credit applications are declined by the formal financial sector. Behind every declined application is a person trying to solve a real-life problem: paying school fees, repairing a vehicle, covering a medical emergency, purchasing stock for a...

Visa adds agentic commerce with OpenAI

Visa has announced a strategic collaboration with OpenAI to enable secure Visa payments within agentic commerce, enabling seamless and trusted payments across OpenAI platforms. Visa will provide its global network, credentialing capabilities and security...

Nvidia partners with SK hynix on memory for AI factories

Nvidia and SK hynix have announced a multiyear technology partnership to advance next-generation memory for the global AI factory buildout and accelerate semiconductor design and manufacturing. “AI factories are the engines of the next industrial revolution, and...

Roelof Botha joins SpaceX board

Venture capitalist Roelof Botha, a long-time ally of Elon Musk, has been appointed to the SpaceX board. Just days after SpaceX concluded its initial public offering, Botha has been appointed as an independent common stock director, effective 16 June 2026. He will also...
Why don’t cancer medicines work the same for everyone?

Why don’t cancer medicines work the same for everyone?

By Susanna Ray – Cancer treatment has become more precise over time, as doctors first classified the disease by where it began in the body and, more recently, by the mutations found inside cancer cells to help find the right drugs to treat it. But why can two...